Teleflex Incorporated (TFX)
NYSE·Healthcare·Medical - Instruments & Supplies
$134.89
-0.13%
Mkt Cap $6.14B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $919.31M | $569.00M | -38.11% | $3.73 | $1.93 | -48.26% | — | — |
| Q4 2025 Nov 6, 2025 | $914.95M | $913.02M | -0.21% | $3.38 | $3.67 | +8.58% | — | — |
| Q3 2025 Jul 31, 2025 | $892.93M | $780.89M | -12.55% | $3.36 | $3.73 | +11.01% | — | — |
| Q2 2025 May 1, 2025 | $766.13M | $700.67M | -8.54% | $2.88 | $2.91 | +1.04% | — | — |
| Q1 2025 Feb 27, 2025 | $767.14M | $795.41M | +3.68% | $3.86 | $3.89 | +0.78% | — | — |
| Q4 2024 Oct 31, 2024 | $813.32M | $764.38M | -6.02% | $3.38 | $3.49 | +3.25% | — | — |
| Q3 2024 Aug 1, 2024 | $762.98M | $749.69M | -1.74% | $3.33 | $3.42 | +2.70% | — | — |
| Q2 2024 May 2, 2024 | $726.89M | $737.85M | +1.51% | $3.07 | $3.21 | +4.56% | — | — |
| Q1 2024 Feb 22, 2024 | $768.69M | $773.91M | +0.68% | $3.26 | $3.38 | +3.68% | — | — |
| Q4 2023 Nov 2, 2023 | $733.56M | $746.39M | +1.75% | $3.27 | $3.64 | +11.31% | — | — |
| Q3 2023 Aug 3, 2023 | $729.91M | $743.26M | +1.83% | $3.21 | $3.41 | +6.23% | — | — |
| Q2 2023 May 4, 2023 | $686.86M | $710.93M | +3.50% | $2.97 | $3.09 | +4.04% | — | — |
| Q1 2023 Feb 23, 2023 | $760.35M | $758.00M | -0.31% | $3.44 | $3.52 | +2.33% | — | — |
| Q4 2022 Oct 27, 2022 | $691.53M | $686.79M | -0.69% | $3.10 | $3.27 | +5.48% | — | — |
| Q3 2022 Jul 28, 2022 | $719.52M | $704.54M | -2.08% | $3.35 | $3.39 | +1.19% | — | — |
| Q2 2022 Apr 28, 2022 | $631.89M | $641.72M | +1.56% | $2.73 | $2.88 | +5.49% | — | — |
| Q1 2022 Feb 24, 2022 | $749.61M | $761.91M | +1.64% | $3.53 | $3.60 | +1.98% | — | — |
| Q4 2021 Oct 28, 2021 | $699.85M | $700.25M | +0.06% | $3.03 | $3.51 | +15.84% | — | — |
| Q3 2021 Jul 29, 2021 | $685.91M | $713.47M | +4.02% | $2.86 | $3.35 | +17.13% | — | — |
| Q2 2021 Apr 29, 2021 | $626.25M | $633.92M | +1.23% | $2.44 | $2.87 | +17.62% | — | — |